PWMG
DSGN icon

Private Wealth Management Group’s Design Therapeutics DSGN Stock Holding History

Private Wealth Management Group’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.71K Hold
533
– – ﹤0.01% 660
2026
Q1 		$5.67K Sell
533
-25
-4% -$253 ﹤0.01% 724
2025
Q4 		$5.24K Hold
558
– – ﹤0.01% 750
2025
Q3 		$4.2K Hold
558
– – ﹤0.01% 863
2025
Q2 		$1.88K Hold
558
– – ﹤0.01% 1101
2025
Q1 		$2.15K Hold
558
– – ﹤0.01% 1027
2024
Q4 		$3.44K Hold
558
– – ﹤0.01% 892
2024
Q3 		$3K Hold
558
– – ﹤0.01% 920
2024
Q2 		$1.87K Hold
558
– – ﹤0.01% 1072
2024
Q1 		$2.25K Buy
+558
New +$1.49K ﹤0.01% 913

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Private Wealth Management Group's DSGN Position: Q2 2026 in Review

Private Wealth Management Group held its Design Therapeutics (DSGN) position steady in Q2 2026 at 533 shares worth $7.71K. The position accounts for ﹤0.01% of the portfolio, ranked #660.

Private Wealth Management Group first reported a position in DSGN in Q1 2024 and has held it in 10 quarters since. 137 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

  • Private Wealth Management Group held 533 shares of Design Therapeutics worth $7.71K as of Q2 2026.
  • Private Wealth Management Group left its Design Therapeutics share count unchanged in Q2 2026.
  • Design Therapeutics made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #660 holding.
  • Private Wealth Management Group first reported a position in Design Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 137 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.